Following National Advertising Division Inquiry, Ezra AI Voluntarily Discontinues Claims for Full Body MRI Medical Service
New York, NY – May 27, 2025 – In a BBB National Programs National Advertising Division challenge brought by Prenuvo, Inc., Ezra AI Inc. voluntarily discontinued comparative advertising claims for its Medical Service: Full Body MRI.
Prenuvo and Ezra are competitors in whole-body medical MRI scans. Prenuvo challenged claims on Ezra's website comparing the services offered by Ezra to those offered by Prenuvo, arguing that Ezra’s advertising misleadingly conveyed the unsupported message that Ezra’s services are superior to those offered by Prenuvo.
During the challenge, Ezra voluntarily permanently discontinued all of the challenged claims. The voluntarily discontinued claims will be treated, for compliance purposes, as though NAD recommended they be discontinued.
In its advertiser statement, Ezra stated it “agrees to comply with NAD’s recommendations, which were voluntarily undertaken by Ezra.”
All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Per NAD/NARB Procedures, this release may not be used for promotional purposes.
Prenuvo and Ezra are competitors in whole-body medical MRI scans. Prenuvo challenged claims on Ezra's website comparing the services offered by Ezra to those offered by Prenuvo, arguing that Ezra’s advertising misleadingly conveyed the unsupported message that Ezra’s services are superior to those offered by Prenuvo.
During the challenge, Ezra voluntarily permanently discontinued all of the challenged claims. The voluntarily discontinued claims will be treated, for compliance purposes, as though NAD recommended they be discontinued.
In its advertiser statement, Ezra stated it “agrees to comply with NAD’s recommendations, which were voluntarily undertaken by Ezra.”
All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Per NAD/NARB Procedures, this release may not be used for promotional purposes.